Telix Pharmaceuticals
Commercializes prostate-cancer imaging agents while developing radiopharmaceutical diagnostics and treatments.
$11.29
After-hours close+0.02 (+0.18%)
At close$11.27(−0.92%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 0.76%2.57M sharesInsiders 7.57%25.64M sharesOther 91.67%310.57M shares
Shares outstanding 338.78M · Float 272.81M · 80.5% free float
Institutions13F, as of Mar 31, 2026
39 holders · 2.57M shares · 10 new positions · 27 increased · 8 reduced · 11 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 564.8K | 0.17% | +441.2K | May 15, 2026 |
| Portolan Capital Management, LLC | 541.3K | 0.16% | +541.3Knew | May 15, 2026 |
| Lazard Asset Management LLC | 289.9K | 0.09% | +39.4K | May 15, 2026 |
| Portland Investment Counsel Inc. | 266.2K | 0.08% | 0 | May 14, 2026 |
| Private Advisor Group, LLC | 174.4K | 0.05% | +128.1K | Apr 27, 2026 |
| Integrated Wealth Concepts LLC | 164.4K | 0.05% | +164.4Knew | May 15, 2026 |
| Raiffeisen Bank International AG | 130.0K | 0.04% | +130.0Knew | Apr 24, 2026 |
| Morgan Stanley | 116.4K | 0.03% | +98.8K | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Behrenbruch Christian | 6.97% | 23.33M | 13G | Feb 14, 2025 ↗ |
| Kluge Andreas | 6.78% | 22.68M | 13G | Feb 14, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Christian Behrenbruch | director, officer: MD & Group CEO | 21.00M | 6.20% | May 6, 2026 |
| Mark Alexander Nelson | director | 3.63M | 1.07% | Apr 1, 2026 |
| Jann Elizabeth Skinner | director | 595.0K | 0.18% | Mar 18, 2026 |
| David Norman Cade | officer: Group Chief Medical Officer | 373.1K | 0.11% | Apr 1, 2026 |
| Darren Joel Patti | officer: Group Chief Operating Officer | 25.6K | 0.01% | Apr 1, 2026 |
| Darren Charlton Smith | officer: Group Chief Financial Officer | 11.9K | 0.00% | Apr 1, 2026 |
| Marie Elizabeth McDonald | director | 3.7K | 0.00% | Mar 18, 2026 |
1 person has not refiled in the last 18 months (3.4K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 28, 2026 | Christian Behrenbruchdirector, officer: MD & Group CEO | Purchase | 34,500 | $14.48 | 20,709,500 |
| Apr 29, 2026 | Christian Behrenbruchdirector, officer: MD & Group CEO | Purchase | 33,435 | $14.87 | 20,742,935 |
CongressHouse and Senate disclosures
Not reported.